Read Bio ContactThousands of people in British Columbia will benefit from BC PharmaCare’s new and expanded coverage of medications used to treat alcohol-use disorder, vision loss, childhood growth failure and lysosomal acid lipase deficiency. Kanuma (sebelipase alfa) is a medication used to treat lysosomal acid lipase deficiency (LAL-D), a condition that makes it difficult to break down and use fats and cholesterol, is administered as an infusion by a health-care professional. These changes ensure that coverage is aligned with clinical evidence and will improve patient access to appropriate medications